Our extensive portfolio of assays provides the crucial information needed for informed drug development decisions. Our unwavering commitment to customer service ensures each assay is optimized to your specific cell line and compound testing requirements, delivering the most predictive data possible.
Characterize efficacy and identify relevant mutations/biomarkers that predict activity in panels of tumor cell lines.
Available in 2D/3D cultures.
Our unique 2D/3D platform to assess the efficacy of therapeutic antibodies in mixed cell populations.
More information
Explore our oncolytic virus set of tools for efficacy assessment in tumor cell lines. Available in 2D and 3D cultures.
More information